FDA to Approve New Generics, But Health Care Savings Will Be Minimal

In 1984 the Hatch-Waxman Act made it cheaper and easier to put generic versions of a drug on the market. As a result of the expedited approval process, generics now make up more than 60 percent of prescription drugs sold in the U.S. and have saved the health care system $734 billion between 1999 and 2008 alone

Read the original post:
FDA to Approve New Generics, But Health Care Savings Will Be Minimal